S Marreaud Selected Research

brostallicin

1/2014	Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study.
6/2011	Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Marreaud Research Topics

Disease

11	Sarcoma (Soft Tissue Sarcoma) 01/2017 - 09/2006
8	Neoplasms (Cancer) 07/2016 - 12/2004
3	Hemangiosarcoma (Angiosarcoma) 01/2017 - 11/2008
2	Breast Neoplasms (Breast Cancer) 01/2017 - 01/2013
2	Leiomyosarcoma 06/2011 - 04/2007
2	Fatigue 04/2008 - 12/2004
1	Epithelioid Hemangioendothelioma 01/2017
1	Cardiotoxicity 01/2017
1	Hypertension (High Blood Pressure) 11/2015
1	Smooth Muscle Tumor 03/2014
1	Alopecia (Baldness) 01/2014
1	Mucositis 01/2014
1	Neutropenia 01/2014
1	Liposarcoma 06/2011
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2011
1	Diarrhea 04/2008
1	Exanthema (Rash) 04/2008
1	Nausea 04/2008
1	Stomatitis 04/2008
1	Colorectal Neoplasms (Colorectal Cancer) 04/2008

Drug/Important Bio-Agent (IBA)

5	pazopanib FDA Link 01/2017 - 06/2011
5	Ifosfamide FDA LinkGeneric 07/2016 - 09/2006
3	AnthracyclinesIBA 01/2017 - 04/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2014 - 01/2014
2	brostallicinIBA 01/2014 - 06/2011
2	Docetaxel (Taxotere)FDA Link 01/2013 - 06/2011
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2011 - 11/2008
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Trastuzumab (Herceptin)FDA Link 01/2017
1	AntigensIBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2016
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 11/2015
1	Biomarkers (Surrogate Marker)IBA 11/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2015
1	Hemoglobins (Hemoglobin)IBA 03/2014
1	A-Form DNA (A-DNA)IBA 01/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2013
1	Lapatinib (GW572016)FDA Link 01/2013
1	human ERBB2 proteinIBA 01/2013
1	CytokinesIBA 08/2012
1	Gemcitabine FDA Link 06/2011
1	TrabectedinIBA 06/2011
1	Dacarbazine (DIC)FDA LinkGeneric 06/2011
1	perifosineIBA 06/2011
1	Temozolomide (Temodar)FDA LinkGeneric 06/2011
1	Cisplatin (Platino)FDA LinkGeneric 05/2011
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2011
1	Etoposide (VP 16)FDA LinkGeneric 05/2011
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2008
1	((S)- 2- (5- (1,2- dihydro- 3- methyl- 1- oxobenzo(f)- quinazoline- 9- yl)methyl)amino- 1- oxo- 2- isoindolynyl)- glutaric acidIBA 04/2008
1	Thymidylate SynthaseIBA 04/2008
1	exatecan (DX 8951f)IBA 04/2007
1	Topoisomerase I InhibitorsIBA 04/2007
1	liposomal doxorubicin (Doxil)FDA Link 09/2006
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 12/2004
1	Pharmaceutical PreparationsIBA 12/2004
1	Alkaline PhosphataseIBA 12/2004
1	Viscum ribosome inactivating proteinIBA 12/2004
1	mistletoe lectin IIBA 12/2004
1	Transaminases (Aminotransferases)IBA 12/2004

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2017 - 04/2007
2	Therapeutics 01/2014 - 01/2013
1	Adjuvant Chemotherapy 12/2014
1	Neoadjuvant Therapy 01/2013
1	Radiotherapy 11/2008
1	Drug Tapering 04/2008